Jefferies Adjusts Noile-Immune Biotech's Price Target to 440 Yen From 800 Yen, Keeps at Buy
Jefferies Adjusts Noile-Immune Biotech's Price Target to 440 Yen From 800 Yen, Keeps at Buy
杰富瑞集团将Noile-Immune Biotech的目标股价从800日元调整为440日元，维持买入水平
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间